Skip to main content
Top
Published in: Sleep and Breathing 4/2015

01-12-2015 | Original Article

The impact of obstructive sleep apnea on high-sensitivity C-reactive protein in subjects with or without metabolic syndrome

Authors: Wei-Te Wu, Su-Shan Tsai, Tung-Sheng Shih, Ming-Hsiu Lin, Tzu-Chieh Chou, Hua Ting, Trong-Neng Wu, Saou-Hsing Liou

Published in: Sleep and Breathing | Issue 4/2015

Login to get access

Abstract

Background

It is unclear whether obstructive sleep apnea (OSA) is independently associated with increased levels of the acute-phase reactant C-reactive protein (CRP). The purpose of this study was to evaluate the relationship between OSA and high-sensitivity CRP (hs-CRP) levels according to the presence or absence of metabolic syndrome (MetS).

Methods

This study recruited 245 male bus drivers from one transportation company in Taiwan. Each participant was evaluated by a polysomnography (PSG) test, blood lipids examination, and hs-CRP. Severity of OSA was categorized according to the apnea-hypopnea index (AHI).

Results

Subjects were categorized into severe OSA group (n = 44; 17.9 %), moderate and mild OSA group (n = 117; 47.8 %), and non-OSA group (n = 84; 34.3 %). AHI had a significant association with hs-CRP (β = 0.125, p = 0.009) adjusting for age, smoking, drinking, and MetS status. Hs-CRP was elevated with severe OSA (β = 0.533, p = 0.005) even adjusting for BMI and MetS. Moreover, there was an independent effect for adjusted odds ratios (AORs) between the stratification of the severity for OSA and MetS.

Conclusion

Elevated hs-CRP level is associated with severe OSA, independent of known confounders. The effect of OSA in CRP is independent of MetS was identified.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lindberg E, Gislason T (2000) Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 4:411–433CrossRefPubMed Lindberg E, Gislason T (2000) Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 4:411–433CrossRefPubMed
3.
go back to reference Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1239CrossRefPubMed Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1239CrossRefPubMed
4.
go back to reference Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384CrossRefPubMed Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384CrossRefPubMed
5.
go back to reference Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep heart health study. JAMA 283:1829–1836CrossRefPubMed Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep heart health study. JAMA 283:1829–1836CrossRefPubMed
6.
go back to reference Ip MS, Lam B, Ng MM, Lam WK et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676CrossRefPubMed Ip MS, Lam B, Ng MM, Lam WK et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676CrossRefPubMed
7.
go back to reference Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682CrossRefPubMed Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682CrossRefPubMed
8.
go back to reference Kiely JL, McNicholas WT (2000) Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 16:128–133CrossRefPubMed Kiely JL, McNicholas WT (2000) Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 16:128–133CrossRefPubMed
9.
go back to reference Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK (2002) Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122:829–839CrossRefPubMed Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK (2002) Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122:829–839CrossRefPubMed
10.
go back to reference Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 7:677–685PubMed Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 7:677–685PubMed
11.
go back to reference Garvey JF, Taylor CT, McNicholas WT (2009) Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 33:1195–1205CrossRefPubMed Garvey JF, Taylor CT, McNicholas WT (2009) Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 33:1195–1205CrossRefPubMed
12.
go back to reference Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179–184CrossRefPubMed Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179–184CrossRefPubMed
13.
go back to reference Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134CrossRefPubMed Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134CrossRefPubMed
14.
go back to reference Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462–2464CrossRefPubMed Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462–2464CrossRefPubMed
15.
go back to reference Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E (2007) Correlates of serum C-reactive protein (CRP)–no association with sleep duration or sleep disordered breathing. Sleep 30:991–996PubMedCentralPubMed Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E (2007) Correlates of serum C-reactive protein (CRP)–no association with sleep duration or sleep disordered breathing. Sleep 30:991–996PubMedCentralPubMed
16.
go back to reference Tasali E, Ip MS (2008) Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 5:207–217CrossRefPubMed Tasali E, Ip MS (2008) Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 5:207–217CrossRefPubMed
17.
go back to reference AASM (2001) The international classification of sleep disorders : diagnostic and coding manual. American Academy of Sleep Medicine, Westchester AASM (2001) The international classification of sleep disorders : diagnostic and coding manual. American Academy of Sleep Medicine, Westchester
18.
go back to reference Ruehland WR, Rochford PD, O’Donoghue FJ, Pierce RJ, Singh P, Thornton AT (2009) The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep 32:150–157PubMedCentralPubMed Ruehland WR, Rochford PD, O’Donoghue FJ, Pierce RJ, Singh P, Thornton AT (2009) The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep 32:150–157PubMedCentralPubMed
20.
go back to reference Lin YC, Yen LL, Chen SY et al (2003) Prevalence of overweight and obesity and its associated factors: findings from national nutrition and health survey in Taiwan, 1993–1996. Prev Med 37:233–241CrossRefPubMed Lin YC, Yen LL, Chen SY et al (2003) Prevalence of overweight and obesity and its associated factors: findings from national nutrition and health survey in Taiwan, 1993–1996. Prev Med 37:233–241CrossRefPubMed
21.
go back to reference Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC (2004) Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 79:31–39PubMed Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC (2004) Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 79:31–39PubMed
22.
go back to reference Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR (2008) C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation 118:2243–2251PubMedCentralCrossRefPubMed Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR (2008) C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation 118:2243–2251PubMedCentralCrossRefPubMed
23.
go back to reference Harris TB, Ferrucci L, Tracy RP et al (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506–512CrossRefPubMed Harris TB, Ferrucci L, Tracy RP et al (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506–512CrossRefPubMed
24.
go back to reference Kanagy NL, Walker BR, Nelin LD (2001) Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 37:511–515CrossRefPubMed Kanagy NL, Walker BR, Nelin LD (2001) Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 37:511–515CrossRefPubMed
25.
go back to reference Lesske J, Fletcher EC, Bao G, Unger T (1997) Hypertension caused by chronic intermittent hypoxia–influence of chemoreceptors and sympathetic nervous system. J Hypertens 15:1593–1603CrossRefPubMed Lesske J, Fletcher EC, Bao G, Unger T (1997) Hypertension caused by chronic intermittent hypoxia–influence of chemoreceptors and sympathetic nervous system. J Hypertens 15:1593–1603CrossRefPubMed
26.
go back to reference Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176:706–712CrossRefPubMed Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176:706–712CrossRefPubMed
27.
go back to reference Kohler M, Ayers L, Pepperell JC et al (2009) Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 64:67–73CrossRefPubMed Kohler M, Ayers L, Pepperell JC et al (2009) Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 64:67–73CrossRefPubMed
28.
go back to reference West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR (2007) Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62:969–974PubMedCentralCrossRefPubMed West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR (2007) Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62:969–974PubMedCentralCrossRefPubMed
29.
go back to reference Minoguchi K, Yokoe T, Tazaki T et al (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625–630CrossRefPubMed Minoguchi K, Yokoe T, Tazaki T et al (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625–630CrossRefPubMed
30.
go back to reference Lui MM, Lam JC, Mak HK et al (2009) C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest 135:950–956CrossRefPubMed Lui MM, Lam JC, Mak HK et al (2009) C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest 135:950–956CrossRefPubMed
31.
go back to reference Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62:509–514PubMedCentralCrossRefPubMed Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62:509–514PubMedCentralCrossRefPubMed
32.
go back to reference IOTF (2000) Asia–Pacific perspective: redefining obesity and its treatment. International Obesity Task Force, Western Pacific Region, Sydney IOTF (2000) Asia–Pacific perspective: redefining obesity and its treatment. International Obesity Task Force, Western Pacific Region, Sydney
Metadata
Title
The impact of obstructive sleep apnea on high-sensitivity C-reactive protein in subjects with or without metabolic syndrome
Authors
Wei-Te Wu
Su-Shan Tsai
Tung-Sheng Shih
Ming-Hsiu Lin
Tzu-Chieh Chou
Hua Ting
Trong-Neng Wu
Saou-Hsing Liou
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 4/2015
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-015-1166-2

Other articles of this Issue 4/2015

Sleep and Breathing 4/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.